IP Library Granted Patent US 6,972,341
Granted Patent B2
US 6,972,341 · App. 10/459,242 · Granted Dec 6, 2005

Prodrugs of GABA analogs, compositions and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,972,341
App. No.
10/459,242
Granted
Dec 6, 2005
Kind
B2
Abstract

The present invention provides prodrugs of GABA analogs, pharmaceutical compositions of prodrugs of GABA analogs and methods for making prodrugs of GABA analogs. The present invention also provides methods for using prodrugs of GABA analogs and methods for using pharmaceutical compositions of prodrugs of GABA analogs for treating or preventing common diseases and/or disorders.

Claims (18)

1. A compound of formula:

or a pharmaceutically acceptable salt, hydrate or solvate thereof wherein:

R 7 and R 14 are each hydrogen;

R 13 is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl and sec-butyl; and

R 25 is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, n-pentyl, isopentyl, sec-pentyl, neopentyl and 1,1-diethoxyethyl.

2. The compound of claim 1 wherein R 13 is methyl.

3. The compound of claim 1 , wherein R 25 is methyl, ethyl, n-propyl or isopropyl.

4. The compound of claim 1 , wherein R 13 is methyl and R 25 is methyl, ethyl, n-propyl or n-butyl.

5. The compound of claim 1 , wherein R 13 is ethyl and R 25 is methyl, n-propyl or isopropyl.

6. The compound of claim 1 , wherein R 13 is n-propyl and R 25 is methyl, ethyl, n-propyl, isopropyl or n-butyl.

7. The compound of claim 1 , wherein R 13 is isopropyl and R 25 is methyl, ethyl, n-propyl, isopropyl, n-butyl or isobutyl.

8. The compound of claim 1 , wherein R 13 is n-propyl and R 25 is n-propyl.

9. The compound of claim 1 , wherein R 13 is methyl and R 25 is ethyl.

10. The compound of claim 1 , wherein R 13 is methyl and R 15 is isopropyl.

11. The compound of claim 1 , wherein R 13 is isopropyl and R 25 is isopropyl.

12. The compound of claim 1 , wherein R 13 is isopropyl and R 25 is 1,1-diethoxyethyl.

13. The compound of claim 1 , wherein R 13 is propyl and R 25 is isopropyl.

14. The compound of claim 1 , wherein R 13 is propyl and R 25 is ethyl.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2021
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ARBOR PHARMACEUTICALS, LLC; WILSHIRE PHARMACEUTICALS, INC.; XENOPORT, INC.
Reel/Frame 057880/0174 →
SECURITY INTEREST Recorded Sep 20, 2021
From: ARBOR PHARMACEUTICALS, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057544/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2018
From: XENOPORT, INC.
To: ARBOR PHARMACEUTICALS, LLC
Reel/Frame 046633/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2018
From: ARBOR PHARMACEUTICALS, LLC
To: XENOPORT, INC.
Reel/Frame 046449/0306 →
SECURITY INTEREST Recorded Jul 6, 2016
From: ARBOR PHARMACEUTICALS, LLC; XENOPORT, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 039266/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2015
From: GALLOP, MARK A.; CUNDY, KENNETH C.; ZHOU, CINDY X.; YAO, FENMEI; XIANG, JIA-NING; OLLMAN, IAN R.; QIU, FAYANG GREGORY
To: XENOPORT, INC.
Reel/Frame 035788/0560 →